How is comprehensive risk management a competitive advantage?
With security incidents and data breaches becoming more prevalent – and more disruptive – sound risk-management frameworks can not only minimize threats but give businesses a competitive advantage.
Adhering to EMIR reporting for derivatives markets
In 2012, the European Market Infrastructure Regulation (EMIR) fundamentally changed derivatives reporting for financial and non-financial counterparties. EMIR regulation shifted again in 2024 with EMIR Refit updates introducing new mandatory requirements. So how can derivatives market participants navigate EMIR reporting and build the correct EU market infrastructure to ensure ongoing compliance?
EU AI Act
As a world-first, the EU’s Artificial Intelligence Act has been introduced as the most comprehensive AI regulation from August 2024 onwards. It is a direct response to the surge of unmonitored AI innovation and usage, which now present dangerous risks to end users and wider communities if misused.
EU NIS2 Directive for Financial Entities
The digital backbone of Europe’s economy, energy grids, transport networks, banks and healthcare, is under constant attack. Escalating cybersecurity threats, with 60% of attacks via phishing, have caused the EU to introduce the NIS2 Directive in an attempt to drastically strengthen cybersecurity and resilience.
FDA 21 CFR Part 11 Compliance in Life Sciences for 2025
In 2025, the life sciences industry continues to advance at a remarkable pace, driven largely by digital transformation.
GMP compliance in life sciences with next-gen tech
Life sciences companies face mounting pressure to meet stringent FDA and EMA manufacturing standards without compromising compliance. Next-gen tech in the form of B2B SaaS compliance solutions is helping pharmaceutical companies to maintain regulatory approval and make strategic advancements.
Pharma compliance solutions and regulatory success
The pharmaceutical industry operates under some of the strictest oversight in the business world, where a single misstep can cost millions and derail years of research. Consequently, robust pharma compliance solutions are fundamental to ensuring regulatory success and achieving operational efficiency.
Danish FSA finds data completeness failings at three major banks
A thematic study by the Danish financial regulator has identified data completeness and recordkeeping failures relating to voice and electronic communications at Danske Bank, Jyske Bank, and Nykredit Bank.
ACER shows suspicious transaction reports are rising across EU energy markets under new REMIT
The first-of-its-kind assessment looks at how regulators are processing reports of potential financial misconduct within wholesale energy markets and offers suggestions for PPATs to improve reporting amidst increased regulatory scrutiny.
EU Taxonomy Regulation
The Conduct Chronicles – Fast and furious: The Regulatory Hazards of Fast Growth
While rapid growth can signal success, without proper governance and risk management, it can quickly spiral into regulatory trouble. This edition of The Conduct Chronicles explores how companies scaling too fast often face compliance failures, consumer backlash, and heightened scrutiny.